BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,361,280 | +4.6% | 672,000 | +26.3% | 0.50% | +8.9% |
| Q2 2023 | $24,237,920 | +12.3% | 532,000 | 0.0% | 0.46% | +6.7% |
| Q1 2023 | $21,577,920 | -20.4% | 532,000 | 0.0% | 0.43% | -20.1% |
| Q4 2022 | $27,116,040 | -5.4% | 532,000 | 0.0% | 0.54% | -17.5% |
| Q3 2022 | $28,654,000 | -8.6% | 532,000 | +9.0% | 0.66% | -1.2% |
| Q2 2022 | $31,344,000 | -17.2% | 488,000 | 0.0% | 0.66% | -8.3% |
| Q1 2022 | $37,840,000 | -9.7% | 488,000 | 0.0% | 0.72% | -4.2% |
| Q4 2021 | $41,890,000 | +6.7% | 488,000 | 0.0% | 0.76% | -5.4% |
| Q3 2021 | $39,250,000 | -0.1% | 488,000 | 0.0% | 0.80% | +0.6% |
| Q2 2021 | $39,284,000 | -4.6% | 488,000 | 0.0% | 0.79% | -8.8% |
| Q1 2021 | $41,158,000 | +5.1% | 488,000 | 0.0% | 0.87% | -1.6% |
| Q4 2020 | $39,157,000 | +6.3% | 488,000 | +6.6% | 0.88% | -5.7% |
| Q3 2020 | $36,832,000 | +37.1% | 458,000 | +46.8% | 0.94% | +30.6% |
| Q2 2020 | $26,863,000 | +125.9% | 312,000 | +113.0% | 0.72% | +94.1% |
| Q1 2020 | $11,894,000 | -80.5% | 146,500 | -83.5% | 0.37% | -83.2% |
| Q1 2015 | $60,965,000 | -6.5% | 890,000 | 0.0% | 2.21% | -3.3% |
| Q4 2014 | $65,228,000 | +2.1% | 890,000 | 0.0% | 2.28% | -0.3% |
| Q3 2014 | $63,875,000 | -0.7% | 890,000 | 0.0% | 2.29% | -1.1% |
| Q2 2014 | $64,347,000 | -1.7% | 890,000 | 0.0% | 2.32% | -4.2% |
| Q1 2014 | $65,486,000 | +5.8% | 890,000 | 0.0% | 2.42% | +4.9% |
| Q4 2013 | $61,900,000 | +5.9% | 890,000 | 0.0% | 2.31% | -2.6% |
| Q3 2013 | $58,464,000 | -5.2% | 890,000 | 0.0% | 2.37% | -7.0% |
| Q2 2013 | $61,650,000 | – | 890,000 | – | 2.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |